Marti Technologies Inc. (MRT)
AMEX: MRT
· Real-Time Price · USD
2.32
0.04 (1.75%)
At close: Oct 15, 2025, 3:59 PM
2.34
0.86%
After-hours: Oct 15, 2025, 04:10 PM EDT
1.75% (1D)
Bid | 2.25 |
Market Cap | 180.79M |
Revenue (ttm) | 24.58M |
Net Income (ttm) | -71.29M |
EPS (ttm) | -1.13 |
PE Ratio (ttm) | -2.05 |
Forward PE | -17.61 |
Analyst | Buy |
Dividends | n/a |
Ask | 2.43 |
Volume | 56,496 |
Avg. Volume (20D) | 122,468 |
Open | 2.26 |
Previous Close | 2.28 |
Day's Range | 2.20 - 2.34 |
52-Week Range | 1.81 - 3.89 |
Beta | 0.28 |
Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for MRT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+17%
Marti Technologies shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
+9.93%
Marti Technologies shares are trading higher after Benchmark initiated coverage on the stock with a Buy rating and announced a $5 price target.

3 weeks ago · seekingalpha.com
Monte Rosa: H1 2026 NEK7 Protein Degrader MRT-8102 Data Could Be Added POCMonte Rosa secured a second major Novartis deal, adding $120M upfront and up to $5.7B in milestones to its cash reserves. GLUE advances MRT-8102, a NEK7 molecular glue degrader, into Phase 1 trials ta...

2 months ago · seekingalpha.com
Morguard Real Estate Investment Trust (MGRUF) Q2 2025 Earnings Call TranscriptMorguard Real Estate Investment Trust (OTC:MGRUF) Q2 2025 Earnings Conference Call July 31, 2025 4:00 PM ET Company Participants Andrew Tamlin - Chief Financial Officer John Ginis - Director of Asset ...